HomeCompareACMSY vs PM

ACMSY vs PM: Dividend Comparison 2026

ACMSY yields 1538.46% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACMSY wins by $883991768.06M in total portfolio value
10 years
ACMSY
ACMSY
● Live price
1538.46%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$883991768.11M
Annual income
$783,774,560,703,885.50
Full ACMSY calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — ACMSY vs PM

📍 ACMSY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACMSYPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACMSY + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACMSY pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACMSY
Annual income on $10K today (after 15% tax)
$130,769.23/yr
After 10yr DRIP, annual income (after tax)
$666,208,376,598,302.60/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, ACMSY beats the other by $666,208,376,596,184.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACMSY + PM for your $10,000?

ACMSY: 50%PM: 50%
100% PM50/50100% ACMSY
Portfolio after 10yr
$441995884.08M
Annual income
$391,887,280,353,188.75/yr
Blended yield
88.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

ACMSY
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACMSY buys
0
PM buys
0
No recent congressional trades found for ACMSY or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACMSYPM
Forward yield1538.46%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$883991768.11M$49.6K
Annual income after 10y$783,774,560,703,885.50$2,492.02
Total dividends collected$876714122.30M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ACMSY vs PM ($10,000, DRIP)

YearACMSY PortfolioACMSY Income/yrPM PortfolioPM Income/yrGap
1← crossover$164,546$153,846.15$11,648$408.29+$152.9KACMSY
2$2,541,933$2,365,868.50$13,589$495.90+$2.53MACMSY
3$36,877,139$34,157,271.11$15,877$603.21+$36.86MACMSY
4$502,577,470$463,118,930.88$18,580$734.88+$502.56MACMSY
5$6,436,433,977$5,898,676,084.35$21,781$896.75+$6436.41MACMSY
6$77,488,345,446$70,601,361,090.44$25,578$1,096.12+$77488.32MACMSY
7$877,278,013,079$794,365,483,451.57$30,092$1,342.17+$877277.98MACMSY
8$9,343,682,184,854$8,404,994,710,859.21$35,470$1,646.46+$9343682.15MACMSY
9$93,660,941,503,130$83,663,201,565,336.92$41,892$2,023.58+$93660941.46MACMSY
10$883,991,768,112,235$783,774,560,703,885.50$49,578$2,492.02+$883991768.06MACMSY

ACMSY vs PM: Complete Analysis 2026

ACMSYStock

Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.

Full ACMSY Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this ACMSY vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACMSY vs SCHDACMSY vs JEPIACMSY vs OACMSY vs KOACMSY vs MAINACMSY vs MOACMSY vs BTIACMSY vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.